Clinical epidemiology - How important now?

Gut

Volumn 54, Issue 5, 2005, Pages 574-575

  Binder, V ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; CANCER RISK; CHRONIC DISEASE; CLINICAL FEATURE; CROHN DISEASE; DISEASE COURSE; DRUG EFFECT; ENTERITIS; EPIDEMIOLOGICAL DATA; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MORTALITY; MYELOID LEUKEMIA; NOTE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES;

EID: 17644384101     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.055111     Document Type: Note

References (10)

1. Askling J, Brandt L, Lapidus A, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 2005;54:617-22.
2. Ljung T, Karlén P, Schmidt D, et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm county. Gut 2004;53:849-53.
3. Winther KV, Jess T, Langholz E, et al. Survival and cause-specific mortality in ulcerative colitis. Follow-up of a population-based cohort in Copenhagen county. Gastroenterology 2003;125:1576-82.
4. Winther KV, Jess T, Langholz E, et al. Long-term risk of cancer in ulcerative colitis; a population-based cohort study from Copenhagen county. Clin Gastroenterol Hepatol 2004;2:1088-95.
5. Jess T, Winther KV, Munkholm P, et al. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen county, Denmark. Gastroenterology 2002;122:1808-14.
6. Jess T, Winther KV, Munkholm P, et al. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen county, Denmark. Aliment Pharmacol Ther 2004;19:287-93.
7. Persson PG, Karlén P, Bernell O, et al. Crohn's disease and cancer: a population-based cohort study. Gastroenterology 1994;107:1675-9.
8. Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991;100:350-8.
9. Palli D, Trallori G, Saieva C, et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence study. Gut 1998;42:175-9.
10. Laftus EV, Tremaine WJ, Habermann TM, et al. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 2000;95:2308-12.